P2Y12 inhibitor reloading for patients with Non-ST-segment Elevation Acute Coronary Syndrome already on Chronic P2Y12 inhibitor therapy in China: Findings From the CCC-ACS (Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome) Projec
The single-center, retrospective comparative study of bivalirudin dose-reduced versus recommended doses in patients with acute coronary syndrome undergoing elective percutaneous coronary intervention